<DOC>
	<DOCNO>NCT00786734</DOCNO>
	<brief_summary>Patients schedule elective PCI randomize pitavastatin 4mg daily without pitavastatin 5 -7days procedure . Creatine kinase-MB , troponin I , myoglobin level measure baseline 8 24 hour procedure ( 1st evaluation ) . After PCI , pitavastatin administer additional 4 week ( 2nd evaluation ) .</brief_summary>
	<brief_title>Pitavastatin Pre-Treatment Study Patient With Elective PCI Stable Angina Pectoris ( PIPA )</brief_title>
	<detailed_description>Procedural ischemic myocardial injury remain frequent complication coronary angioplasty . Recently report pretreatment atorvastatin reduce myocardial damage compare placebo . Thus , evaluate difference pretreatment pitavastatin compare standard therapy reduction myocardial damage patient schedule elective PCI stable angina pectoris .</detailed_description>
	<mesh_term>Angina Pectoris</mesh_term>
	<mesh_term>Angina , Stable</mesh_term>
	<mesh_term>Pitavastatin</mesh_term>
	<criteria>Patients LDL ≥ 100mg/dL Patients schedule elective PCI stable angina Acute myocardial infarction ( &lt; 3 month ) Unstable angina Previous treatment statin ( &lt; 6 month ) Increase CKMB upper normal limit Increase liver enzyme ( AST/ALT ) 2 time upper normal limit Increase serum creatinine 2 time upper normal limit Left ventricular ejection fraction &lt; 30 % Previous treatment glycoprotein Ⅱb/Ⅲa receptor inhibitor ( &lt; 4 week )</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>pitavastatin</keyword>
	<keyword>PCI</keyword>
	<keyword>stable angina</keyword>
</DOC>